Early infantile epileptic encephalopathy due to biallelic pathogenic variants in PIGQ: Report of seven new subjects and review of the literature

Devon L. Johnstone, Thi Tuyet Mai Nguyen, Jessica Zambonin, Kristin D. Kernohan, Anik St-Denis, Nissan V. Baratang, Taila Hartley, Michael T. Geraghty, Julie Richer, Jacek Majewski, Eric Bareke, Andrea Guerin, Manuela Pendziwiat, Loren D.M. Pena, Hilde M.H. Braakman, Karen W. Gripp, Andrew C. Edmondson, Miao He, Rebecca C. Spillmann, Erik A. EklundAllan Bayat, Hugh J. McMillan, Kym M. Boycott*, Philippe M. Campeau

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

18 Citationer (Scopus)

Abstract

We investigated seven children from six families to expand the phenotypic spectrum associated with an early infantile epileptic encephalopathy caused by biallelic pathogenic variants in the phosphatidylinositol glycan anchor biosynthesis class Q (PIGQ) gene. The affected children were all identified by clinical or research exome sequencing. Clinical data, including EEGs and MRIs, was comprehensively reviewed and flow cytometry and transfection experiments were performed to investigate PIGQ function. Pathogenic biallelic PIGQ variants were associated with increased mortality. Epileptic seizures, axial hypotonia, developmental delay and multiple congenital anomalies were consistently observed. Seizure onset occurred between 2.5 months and 7 months of age and varied from treatable seizures to recurrent episodes of status epilepticus. Gastrointestinal issues were common and severe, two affected individuals had midgut volvulus requiring surgical correction. Cardiac anomalies including arrythmias were observed. Flow cytometry using granulocytes and fibroblasts from affected individuals showed reduced expression of glycosylphosphatidylinositol (GPI)-anchored proteins. Transfection of wildtype PIGQ cDNA into patient fibroblasts rescued this phenotype. We expand the phenotypic spectrum of PIGQ-related disease and provide the first functional evidence in human cells of defective GPI-anchoring due to pathogenic variants in PIGQ.

OriginalsprogEngelsk
TidsskriftJournal of Inherited Metabolic Disease
Vol/bind43
Udgave nummer6
Sider (fra-til)1321-1332
Antal sider12
ISSN0141-8955
DOI
StatusUdgivet - nov. 2020
Udgivet eksterntJa

Bibliografisk note

Funding Information:
We wish to thank the patients and their families for participating in this study, without whom none of this would be possible. This work was partially supported by the Care4Rare Canada Consortium funded by Genome Canada and the Ontario Genomics Institute (OGI‐147), the Canadian Institutes of Health Research, Ontario Research Fund, Genome Alberta, Genome British Columbia, Genome Quebec, Fonds de la recherche en santé du Quebec and Children's Hospital of Eastern Ontario Foundation. Research reported in this manuscript was also supported by the NIH Common Fund through the Office of Strategic Coordination/Office of the NIH Director under Award Number(s) [U01HG007672 (PI Dr. Vandana Shashi, Duke University)] and NIH grant T32GM008638 (Andrew C. Edmondson). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Devon L. Johnstone was supported by a Vanier Canada Graduate Scholarship. Kym M. Boycott was supported by a CIHR Foundation Grant (FDN‐154279) and a Tier 1 Canada Research Chair in Rare Disease Precision Health.

Publisher Copyright:
© 2020 The Authors. Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.

Citationsformater